Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang Wo

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Thoracic Disease|April 17, 2023
Identified optimal candidates for pulmonary resection in octogenarians with non-small cell lung cancer: a web-based predictive modelYizhou Peng, Yang Wo, Pengcheng Liu, et al.
Molecular Medicine (Cambridge, Mass.)|August 15, 2020
Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancerDantong Sun, Lu Tian, Yan Zhu, et al.
Clinical Lung Cancer|April 7, 2023
Lobe-Specific Lymph Node Dissection May be Feasible for Clinical N0 Solid-Predominant Part-Solid Lung Adenocarcinoma With Solid Component Diameter ≤ 2 cmYang Wo, Hang Li, Zhencong Chen, et al.
Peerj|May 9, 2019
Identification of a putative competitive endogenous RNA network for lung adenocarcinoma using TCGA datasetsYuanyong Wang, Tong Lu, Yang Wo, et al.
Oncotargets and Therapy|November 5, 2020
Desmoglein 3 and Keratin 14 for Distinguishing Between Lung Adenocarcinoma and Lung Squamous Cell CarcinomaYanting Dong, Shicheng Li, Xiao Sun, et al.
Translational Lung Cancer Research|February 11, 2021
Circ-AASDH functions as the progression of early stage lung adenocarcinoma by targeting miR-140-3p to activate E2F7 expressionYuanyong Wang, Yang Wo, Tong Lu, et al.
Experimental Hematology & Oncology|February 24, 2026
Tertiary lymphoid structures correlate with reduced recurrence risk and enhanced antitumor immunity in esophageal squamous cell carcinoma with pathologic non-complete response to neoadjuvant chemoimmunotherapyYang Wo, Tong Lu, Zijiang Yang, et al.
Cancer Cell International|March 20, 2019
Identification of DNA methylation-driven genes in esophageal squamous cell carcinoma: a study based on The Cancer Genome AtlasTong Lu, Di Chen, Yuanyong Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|July 3, 2022
The impact of station 4L lymph node dissection on short-term and long-term outcomes in non-small cell lung cancerYang Wo, Hang Li, Yang Zhang, et al.
Translational Lung Cancer Research|April 23, 2021
circFBXW7 attenuates malignant progression in lung adenocarcinoma by sponging miR-942-5pYanting Dong, Tong Qiu, Yunpeng Xuan, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Thoracic Disease|April 17, 2023
Identified optimal candidates for pulmonary resection in octogenarians with non-small cell lung cancer: a web-based predictive modelYizhou Peng, Yang Wo, Pengcheng Liu, et al.
Molecular Medicine (Cambridge, Mass.)|August 15, 2020
Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancerDantong Sun, Lu Tian, Yan Zhu, et al.
Clinical Lung Cancer|April 7, 2023
Lobe-Specific Lymph Node Dissection May be Feasible for Clinical N0 Solid-Predominant Part-Solid Lung Adenocarcinoma With Solid Component Diameter ≤ 2 cmYang Wo, Hang Li, Zhencong Chen, et al.
Peerj|May 9, 2019
Identification of a putative competitive endogenous RNA network for lung adenocarcinoma using TCGA datasetsYuanyong Wang, Tong Lu, Yang Wo, et al.
Oncotargets and Therapy|November 5, 2020
Desmoglein 3 and Keratin 14 for Distinguishing Between Lung Adenocarcinoma and Lung Squamous Cell CarcinomaYanting Dong, Shicheng Li, Xiao Sun, et al.
Translational Lung Cancer Research|February 11, 2021
Circ-AASDH functions as the progression of early stage lung adenocarcinoma by targeting miR-140-3p to activate E2F7 expressionYuanyong Wang, Yang Wo, Tong Lu, et al.
Experimental Hematology & Oncology|February 24, 2026
Tertiary lymphoid structures correlate with reduced recurrence risk and enhanced antitumor immunity in esophageal squamous cell carcinoma with pathologic non-complete response to neoadjuvant chemoimmunotherapyYang Wo, Tong Lu, Zijiang Yang, et al.
Cancer Cell International|March 20, 2019
Identification of DNA methylation-driven genes in esophageal squamous cell carcinoma: a study based on The Cancer Genome AtlasTong Lu, Di Chen, Yuanyong Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|July 3, 2022
The impact of station 4L lymph node dissection on short-term and long-term outcomes in non-small cell lung cancerYang Wo, Hang Li, Yang Zhang, et al.
Translational Lung Cancer Research|April 23, 2021
circFBXW7 attenuates malignant progression in lung adenocarcinoma by sponging miR-942-5pYanting Dong, Tong Qiu, Yunpeng Xuan, et al.
Pageof 3